Rafferty Asset Management
PRAX icon

Rafferty Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Rafferty Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.84M Sell
11,470
-3,718
-24% -$1.18M 0.01% 427
2026
Q1 		$4.89M Sell
15,188
-7,052
-32% -$2.18M 0.02% 364
2025
Q4 		$6.56M Sell
22,240
-15,333
-41% -$2.86M 0.02% 344
2025
Q3 		$1.99M Buy
37,573
+12,768
+51% +$619K 0.01% 649
2025
Q2 		$1.04M Sell
24,805
-4,440
-15% -$169K ﹤0.01% 759
2025
Q1 		$1.11M Sell
29,245
-4,384
-13% -$274K ﹤0.01% 720
2024
Q4 		$2.59M Sell
33,629
-1,730
-5% -$125K 0.01% 572
2024
Q3 		$2.03M Sell
35,359
-5,999
-15% -$324K 0.01% 631
2024
Q2 		$1.71M Buy
+41,358
New +$1.95M 0.01% 689
2022
Q3 		– Sell
-15,323
Closed -$563K – 1222
2022
Q2 		$563K Buy
15,323
+10,643
+227% +$1.14M 0.01% 777
2022
Q1 		$717K Buy
4,680
+181
+4% +$37.2K ﹤0.01% 854
2021
Q4 		$1.33M Buy
+4,499
New +$1.32M 0.01% 779
2021
Q2 		– Sell
-2,506
Closed -$1.23M – 1268
2021
Q1 		$1.23M Buy
+2,506
New +$1.78M 0.01% 725

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Rafferty Asset Management's PRAX Position: Q2 2026 in Review

Rafferty Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 24% in Q2 2026, selling an estimated $1.18M and leaving 11,470 shares worth $3.84M. The position accounts for 0.01% of the portfolio, ranked #427.

Rafferty Asset Management first reported a position in PRAX in Q1 2021 and has held it in 13 quarters since. The position peaked at $6.56M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Rafferty Asset Management held 11,470 shares of Praxis Precision Medicines worth $3.84M as of Q2 2026.
  • Rafferty Asset Management sold 3,718 Praxis Precision Medicines shares in Q2 2026, an estimated $1.18M.
  • Praxis Precision Medicines made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #427 holding.
  • Rafferty Asset Management first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 13 quarters since.
  • Rafferty Asset Management's Praxis Precision Medicines position peaked at $6.56M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.